Expertise in
57
conditions

Dr. Matthew P. Wicklund

Neurology
University Of Colorado Hospital Authority
1635 Aurora Ct, 
Aurora, CO 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
57
conditions
University Of Colorado Hospital Authority
1635 Aurora Ct, 
Aurora, CO 

Overview

Matthew Wicklund is a Neurologist practicing medicine in Aurora, Colorado.

Dr. Wicklund is highly rated in 57 conditions, according to our data. His clinical expertise encompasses Limb-Girdle Muscular Dystrophy, Inclusion Body Myositis, Limb-Girdle Muscular Dystrophy Type 2I, and Paramyotonia Congenita.

He is actively involved in clinical research, co-authoring 45 peer reviewed articles and participating in 10 clinical trials. Dr. Wicklund is currently accepting new patients.

Specialties

Neurology

Licenses

Psychiatry & Neurology in CO

Hospital Affiliations

University Health System
UT Health San Antonio Multispecialty & Research Ho

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community First Health Plans
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

University of Colorado Hospital Authority
1635 Aurora Ct, Aurora, CO 80045

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)
Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)
Enrollment Status: Recruiting
Publish Date: May 07, 2026
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1, Followed by an Open-Label Extension
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1, Followed by an Open-Label Extension
Enrollment Status: Completed
Publish Date: September 04, 2026
Intervention Type: Drug
Study Drug: Pitolisant
Study Phase: Phase 2
Influence of NT5c1A Antibodies on Disease Progression, Clinical Phenotype and Blood and Muscle Biomarkers in Sporadic Inclusion Body Myositis - A Prospective Evaluation (INSPIRE-IBM Study)
Influence of NT5c1A Antibodies on Disease Progression, Clinical Phenotype and Blood and Muscle Biomarkers in Sporadic Inclusion Body Myositis - A Prospective Evaluation (INSPIRE-IBM Study)
Enrollment Status: Active_not_recruiting
Publish Date: May 27, 2026
GRASP-LGMD: Defining Clinical Endpoints in LGMD
GRASP-LGMD: Defining Clinical Endpoints in LGMD
Enrollment Status: Completed
Publish Date: February 27, 2026
A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Biological
Study Drugs: HYQVIA, Intravenous Immunoglobulin G
Study Phase: Phase 3
Phase II Study of Arimoclomol for the Treatment of Sporadic Inclusion Body Myositis (IBM)
Phase II Study of Arimoclomol for the Treatment of Sporadic Inclusion Body Myositis (IBM)
Enrollment Status: Completed
Publish Date: May 10, 2023
Intervention Type: Other, Drug
Study Phase: Phase 2
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy
Enrollment Status: Terminated
Publish Date: September 26, 2022
Intervention Type: Drug
Study Phase: Phase 2
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen
Enrollment Status: Completed
Publish Date: August 12, 2022
Intervention Type: Drug
Study Phase: Phase 3
An Open-Label, Multi-Center, Study With a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy
An Open-Label, Multi-Center, Study With a Concurrent Untreated Control Arm to Evaluate the Efficacy and Safety of Eteplirsen in Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: January 25, 2021
Intervention Type: Drug
Study Phase: Phase 3
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Enrollment Status: Completed
Publish Date: July 06, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 9 Less Clinical Trials

45 Total Publications

Prospective Study of Video Hand Opening Time as a Quantitative Measurement of Myotonia in Patients With Myotonic Dystrophy Type 1.
Prospective Study of Video Hand Opening Time as a Quantitative Measurement of Myotonia in Patients With Myotonic Dystrophy Type 1.
Journal: Neurology
Published: February 26, 2026
Similar Doctors
Expertise in
18
conditions
Expertise in
18
conditions
Referral may be required

University Of Colorado Hospital Authority

1635 Aurora Ct, 
Aurora, CO 
 (0.1 miles away)
720-848-2080
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Benzi Kluger is a Neurologist practicing medicine in Aurora, Colorado. Dr. Kluger is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Progressive Supranuclear Palsy Atypical, Progressive Supranuclear Palsy, and Gastrostomy.

Expertise in
16
conditions
Expertise in
16
conditions
Referral may be required

Children's Hospital Colorado

13123 E 16th Ave, 
Aurora, CO 
 (0.2 miles away)
720-777-1234
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Scott Demarest is a Neurologist practicing medicine in Aurora, Colorado. Dr. Demarest is highly rated in 16 conditions, according to our data. His clinical expertise encompasses West Syndrome, Spasmus Nutans, Epilepsy, and Rett Syndrome. Dr. Demarest is currently accepting new patients.

Expertise in
17
conditions
Expertise in
17
conditions
Referral may be required

University Of Colorado Denver Hospital

12631 E 17th Ave, 
Aurora, CO 
 (0.1 miles away)
303-724-2194
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Amanda Piquet is a Neurologist practicing medicine in Aurora, Colorado. Dr. Piquet is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Encephalitis, Stiff Person Syndrome, Anti-NMDA Receptor Encephalitis, and Rasmussen Encephalitis. Dr. Piquet is currently accepting new patients.

Frequently Asked Questions about Dr. Matthew P. Wicklund

How do I make an appointment with Dr. Matthew P. Wicklund?

You can book an appointment with Dr. Matthew P. Wicklund by calling their office at 720-848-2080. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Matthew P. Wicklund a top-rated expert for Limb-Girdle Muscular Dystrophy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Matthew P. Wicklund is classified as an Elite expert for Limb-Girdle Muscular Dystrophy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Matthew P. Wicklund specialize in?

While Dr. Matthew P. Wicklund is a Neurology, they have specific expertise in Limb-Girdle Muscular Dystrophy, Inclusion Body Myositis, and Limb-Girdle Muscular Dystrophy Type 2I. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Matthew P. Wicklund participate in research or clinical trials?

Yes. Dr. Matthew P. Wicklund has published 45 articles and abstracts on conditions like Limb-Girdle Muscular Dystrophy. You can view a list of Dr. Matthew P. Wicklund's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Matthew P. Wicklund accept my insurance?

Dr. Matthew P. Wicklund accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 720-848-2080 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wicklund's expertise for a condition
ConditionClose
View All 22 Distinguished Conditions
View All 33 Advanced Conditions
View All 67 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile